X0306 4 2012-08-01 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001242066 JOYCE R TODD MORRIS CORPORATE CENTER III, 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 0 1 0 0 CFO-Global & PAO Common Stock, par value $0.0033 2012-08-01 4 M 0 2612 38.92 A 80847 D Common Stock, par value $0.0033 2012-08-01 4 M 0 4388 38.92 A 85235 D Common Stock, par value $0.0033 2012-08-01 4 M 0 2250 35.11 A 87485 D Common Stock, par value $0.0033 2012-08-01 4 M 0 574 25.64 A 88059 D Common Stock, par value $0.0033 2012-08-01 4 M 0 3426 25.64 A 91485 D Common Stock, par value $0.0033 2012-08-01 4 S 0 2612 78.60 D 88873 D Common Stock, par value $0.0033 2012-08-01 4 S 0 4388 78.60 D 84485 D Common Stock, par value $0.0033 2012-08-01 4 S 0 2250 78.60 D 82235 D Common Stock, par value $0.0033 2012-08-01 4 S 0 574 78.60 D 81661 D Common Stock, par value $0.0033 3283 I Trust Non-Qualified Options to Purchase Common Stock 38.92 2012-08-01 4 M 0 2612 0 D 2005-12-15 2013-08-04 Common Stock, par value $0.0033 2612 0 D Non-Qualified Options to Purchase Common Stock 38.92 2012-08-01 4 M 0 4388 0 D 2005-12-15 2013-08-04 Common Stock, par value $0.0033 4388 0 D Non-Qualified Options to Purchase Common Stock 35.11 2012-08-01 4 M 0 2250 0 D 2008-08-12 2015-08-12 Common Stock, par value $0.0033 2250 0 D Non-Qualified Options to Purchase Common Stock 25.64 2012-08-01 4 M 0 574 0 D 2009-09-01 2016-09-01 Common Stock, par value $0.0033 574 0 D Incentive Stock Options to Purchase Common Stock 25.64 2012-08-01 4 M 0 3426 0 D 2010-09-01 2016-09-01 Common Stock, par value $0.0033 3426 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $78.66, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/R. TODD JOYCE 2012-08-01